Loblaw, a leading grocery retailer, reported increased profits in the second quarter due to strong performance at its discount chains No Frills and Maxi. The company highlighted robust sales growth in its pharmacy unit, attributing it to the popularity of generic GLP-1 weight loss medications.
The Brampton-based retailer disclosed its financial results for the quarter ending June 20, revealing revenue exceeding $15.3 billion, marking a four percent rise from the previous quarter. Profit available to common shareholders also saw a five percent increase, reaching $751 million.
Loblaw noted a 1.6 percent increase in same-store sales for its core retail food business, while its drug retail unit, including Shoppers Drug Mart, experienced a 4.6 percent growth in same-store sales, primarily driven by a 7.5 percent surge in pharmacy and health-care services.
During a conference call with analysts, Loblaw’s chief financial officer, Richard Dufresne, mentioned the positive impact of generic GLP-1 drugs on pharmacy performance. He emphasized that lower generic drug prices were being compensated by higher volumes, leading to expectations of increased revenue, gross profit dollars, and gross margin rates.
The company’s executives also highlighted a significant uptick in sales of GLP-1 drugs, such as Ozemic and Wegovy, which have surged by 40 percent year-to-date. Additionally, Loblaw CEO Per Bank noted a noticeable shift towards consumers choosing frozen vegetables over fresh produce due to inflation, particularly citing a sharp increase in the cost of fresh tomatoes.
Dufresne reiterated Loblaw’s strong position in the market, especially in hard discount banners like No Frills and Maxi, as customers prioritize value amidst food price inflation. The company continues to excel in the hard discount sector while outperforming competitors in conventional retail.
Furthermore, Loblaw shares traded steadily on Thursday, with a year-to-date increase of approximately six percent. The latest data from Statistics Canada indicated a decrease in the inflation rate to 2.8 percent in June, with grocery price hikes moderating to 3.9 percent from the previous month’s 4.3 percent.
Overall, Loblaw’s performance reflects its strategic positioning in the market, emphasizing value for customers amid changing consumer preferences and economic conditions.